Antihypertensive Effect of Enalapril as First-Step Treatment of Mild and Moderate Uncomplicated Essential Hypertension
Authors:
- Paolo SassanoPSPaolo Sassano
- Gilles ChatellierGCGilles Chatellier
- Francois Alhenc-GelasFAFrancois Alhenc-Gelas
- Pierre CorvolPCPierre Corvol
- Joel MenardJMJoel Menard
- 1 August 1984
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (2) , 18-22
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- DOES PLACEBO LOWER BLOOD-PRESSURE?The Lancet, 1981
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.BMJ, 1981
- Blood Pressure Variability in Man: Its Relation to High Blood Pressure, Age and Baroreflex SensitivityClinical Science, 1980
- CIRCADIAN VARIATION OF BLOOD-PRESSUREThe Lancet, 1978